Notice of Meeting, 29772-29773 [2010-12546]
Download as PDF
<![CDATA[
wwoods2 on DSK1DXX6B1PROD with NOTICES
29772
Federal Register / Vol. 75, No. 102 / Thursday, May 27, 2010 / Notices
Contact Person: Carol Hamelink, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4192,
MSC 7850, Bethesda, MD 20892, (301) 213–
9887, hamelinc@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel;
Fellowships: Health and Related Behaviors of
Individuals and Populations.
Date: June 23, 2010.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hilton Alexandria Old Town, 1767
King Street, Alexandria, VA 22314.
Contact Person: Karin F. Helmers, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3166,
MSC 7770, Bethesda, MD 20892, 301–254–
9975, helmersk@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Small
Business: Non-HIV Anti-Infective
Therapeutics.
Date: June 23–24, 2010.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications,
Place: George Washington University Inn,
824 New Hampshire Avenue, NW.,
Washington, DC 20037.
Contact Person: Rossana Berti, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3191,
MSC 7846, Bethesda, MD 20892, 301–402–
6411, bertiros@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel;
Fellowships: Sensory, Motor, and Cognitive
Neuroscience.
Date: June 23, 2010.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: One Washington Circle Hotel, One
Washington Circle, NW., Washington, DC
20037.
Contact Person: John Bishop, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5182,
MSC 7844, Bethesda, MD 20892, (301) 408–
9664, bishopj@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; ARRA:
Chronic Fatigue Syndrome, Fibromyalgia
Syndrome, and Temporomandibular Disorder
Competitive Revisions.
Date: June 23, 2010.
Time: 1 p.m. to 2 p.m.
Agenda: To review and evaluate grant
applications,
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Telephone Conference Call).
Contact Person: Lynn E Luethke, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5166,
MSC 7844, Bethesda, MD 20892, (301) 806–
3323, luethkel@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
VerDate Mar<15>2010
15:26 May 26, 2010
Jkt 220001
Conflicts: Lung Host Defense and Cystic
Fibrosis Applications.
Date: June 23, 2010.
Time: 2 p.m. to 4 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Telephone Conference Call).
Contact Person: Everett E Sinnett, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 2178,
MSC 7818, Bethesda, MD 20892, 301–435–
1016, sinnett@nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Small
Business: Risk Prevention and Health
Behavior.
Date: June 23–25, 2010.
Time: 7 p.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Pier 5 Hotel, 711 Eastern Avenue,
Baltimore, MD 21202.
Contact Person: Claire E. Gutkin, PhD,
MPH, Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3138,
MSC 7759, Bethesda, MD 20892, 301–594–
3139, gutkincl@csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: May 21, 2010.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2010–12788 Filed 5–26–10; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Healthcare Infection Control Practices
Advisory Committee, (HICPAC)
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the following meeting for the
aforementioned committee:
Times and Dates: 9 a.m.–5 p.m., June
17, 2010; 9 a.m.–12 p.m., June 18, 2010.
Place: CDC, Global Communications
Center, Building 19, Auditorium B3,
1600 Clifton Road, NE., Atlanta, Georgia
30333.
Status: This meeting is open to the
public, limited only by the space
available. Please register for the meeting
online at https://www.cdc.gov/hicpac or
by sending an e-mail to hicpac@cdc.gov.
Purpose: The Committee is charged
with providing advice and guidance to
PO 00000
Frm 00067
Fmt 4703
Sfmt 4703
the Secretary, the Assistant Secretary for
Health, the Director, CDC, and the
Director, National Center for Emerging
and Zoonotic Infectious Diseases
(NCEZID) regarding (1) The practice of
healthcare infection control; (2)
strategies for surveillance, prevention,
and control of infections (e.g.,
nosocomial infections), antimicrobial
resistance, and related events in settings
where healthcare is provided; and (3)
periodic updating of guidelines and
other policy statements regarding
prevention of healthcare-associated
infections and healthcare-related
conditions.
Matters to be Discussed: The agenda
will include: Updates on CDC’s
activities for healthcare associated
infections; the draft guideline for the
Prevention of Norovirus Gastroenteritis
Outbreaks in Healthcare Settings; the
draft guideline for prevention of
infections among patients in neonatal
intensive care units (NICU); the draft
guideline for Infection Control in
Healthcare Personnel; and a discussion
of infection control in ambulatory care
settings.
Agenda items are subject to change as
priorities dictate.
Contact Person for More Information:
Michelle King, HICPAC, Division of
Healthcare Quality Promotion, National
Center for Emerging and Zoonotic
Infectious Diseases, CDC, 1600 Clifton
Road, N.E., Mailstop A–07, Atlanta,
Georgia 30333 Telephone (404) 639–
2936. E-mail: hicpac@cdc.gov.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both CDC
and the Agency for Toxic Substances
and Disease Registry.
Dated: May 19, 2010.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. 2010–12749 Filed 5–26–10; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Agency for Healthcare Research and
Quality
Notice of Meeting
In accordance with section 10(d) of
the Federal Advisory Committee Act (5
U.S.C., Appendix 2), announcement is
made of a Health Care Policy and
E:\FR\FM\27MYN1.SGM
27MYN1
Federal Register / Vol. 75, No. 102 / Thursday, May 27, 2010 / Notices
Research Special Emphasis Panel (SEP)
meeting.
A Special Emphasis Panel is a group
of experts in fields related to health care
research who are invited by the Agency
for Healthcare Research and Quality
(AHRQ), and agree to be available, to
conduct on an as needed basis,
scientific reviews of applications for
AHRQ support. Individual members of
the Panel do not attend regularlyscheduled meetings and do not serve for
fixed terms or a long period of time.
Rather, they are asked to participate in
particular review meetings which
require their type of expertise.
Substantial segments of the upcoming
SEP meeting listed below will be closed
to the public in accordance with the
Federal Advisory Committee Act,
section 10 (d) of 5 U.S.C., Appendix 2
and 5 U.S.C. 552b (c)(6). Grant
applications for the Recovery Act 2009
Limited Competition: Prospect
Studies—Building New Clinical
Infrastructure for CE (R01) applications
are to be reviewed and discussed at this
meeting. These discussions are likely to
reveal personal information concerning
individuals associated with the
applications. This information is
exempt from mandatory disclosure
under the above-cited statutes.
SEP Meeting on: Recovery Act 2009
Limited Competition: Prospect Studies—
Building New Clinical Infrastructure for CE
(R01).
Dates: June 16, 2010. (Open on June 16
from 8 a.m. to 8:15 a.m. and closed for the
remainder of the meeting.)
Place: Hyatt Regency Hotel, 7400
Wisconsin Avenue, 1 Bethesda Metro Center,
Conference Room TBD, Bethesda, MD 20814.
Contact Person: Anyone wishing to obtain
a roster of members, agenda or minutes of the
nonconfidential portions of this meeting
should contact Mrs. Bonnie Campbell,
Committee Management Officer, Office of
Extramural Research, Education and Priority
Populations, AHRQ, 540 Gaither Road, Room
2038, Rockville, Maryland 20850, Telephone
(301) 427–1554.
Agenda items for this meeting are subject
to change as priorities dictate.
Dated: May 13, 2010.
Carolyn M. Clancy,
Director.
[FR Doc. 2010–12546 Filed 5–26–10; 8:45 am]
wwoods2 on DSK1DXX6B1PROD with NOTICES
BILLING CODE 4160–90–M
U.S.C., Appendix 2), announcement is
made of a Health Care Policy and
Research Special Emphasis Panel (SEP)
meeting.
A Special Emphasis Panel is a group
of experts in fields related to health care
research who are invited by the Agency
for Healthcare Research and Quality
(AHRQ), and agree to be available, to
conduct on an as needed basis,
scientific reviews of applications for
AHRQ support. Individual members of
the Panel do not attend regularlyscheduled meetings and do not serve for
fixed terms or a long period of time.
Rather, they are asked to participate in
particular review meetings which
require their type of expertise.
Substantial segments of the upcoming
SEP meeting listed below will be closed
to the public in accordance with the
Federal Advisory Committee Act,
section 10(d) of 5 U.S.C., Appendix 2
and 5 U.S.C. 552b(c)(6). Grant
applications for the OS ARRA:
Enhancing Registries for Quality
Improvement and Comparative
Effectiveness (RO 1) applications are to
be reviewed and discussed at this
meeting. These discussions are likely to
reveal personal information concerning
individuals associated with the
applications. This information is
exempt from mandatory disclosure
under the above-cited statutes.
SEP Meeting on: OS ARRA: Enhancing
Registries for Quality Improvement and
Comparative Effectiveness (R01).
Dates: June 18, 2010. (Open on June 18
from 8 a.m. to 8:15 a.m. and closed for the
remainder of the meeting.)
Place: Crowne Plaza Hotel, 3 Research
Court, Conference Room TBD, Rockville, MD
20852.
Contact Person: Anyone wishing to obtain
a roster of members, agenda or minutes of the
non-confidential portions of this meeting
should contact Mrs. Bonnie Campbell,
Committee Management Officer, Office of
Extramural Research, Education and Priority
Populations, AHRQ, 540 Gaither Road, Room
2038, Rockville, Maryland 20850, Telephone
(301) 427–1554.
Agenda items for this meeting are subject
to change as priorities dictate.
Dated: May 13, 2010.
Carolyn M. Clancy,
Director.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
[FR Doc. 2010–12544 Filed 5–26–10; 8:45 am]
Agency for Healthcare Research and
Quality
BILLING CODE 4160–90–M
Notice of Meeting
In accordance with section 10(d) of
the Federal Advisory Committee Act (5
VerDate Mar<15>2010
15:26 May 26, 2010
Jkt 220001
PO 00000
Frm 00068
Fmt 4703
Sfmt 4703
29773
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Diabetes and
Digestive and Kidney Diseases; Notice
of Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Special Emphasis Panel, Collaborative
Interdisciplinary Team Science—Nuclear
Receptors.
Date: June 10, 2010.
Time: 1 p.m. to 3 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Two
Democracy Plaza, 6707 Democracy
Boulevard, Bethesda, MD 20892. (Telephone
Conference Call.)
Contact Person: Robert Wellner, PhD,
Scientific Review Officer, Review Branch,
DEA, NIDDK, National Institutes of Health,
Room 757, 6707 Democracy Boulevard,
Bethesda, MD 20892–5452. (301) 594–4721.
rw175w@nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Special Emphasis Panel, Metabolic Disease
and Pregnancy.
Date: June 10, 2010.
Time: 3:30 p.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Two
Democracy Plaza, 6707 Democracy
Boulevard, Bethesda, MD 20892. (Telephone
Conference Call.)
Contact Person: Carol J. Goter-Robinson,
PhD, Scientific Review Officer, Review
Branch, DEA, NIDDK, National Institutes of
Health, Room 748, 6707 Democracy
Boulevard, Bethesda, MD 20892–5452. (301)
594–7791.
goterrobinsonc@extra.niddk.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
E:\FR\FM\27MYN1.SGM
27MYN1
]]>Agencies
[Federal Register Volume 75, Number 102 (Thursday, May 27, 2010)]
[Notices]
[Pages 29772-29773]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-12546]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Agency for Healthcare Research and Quality
Notice of Meeting
In accordance with section 10(d) of the Federal Advisory Committee
Act (5 U.S.C., Appendix 2), announcement is made of a Health Care
Policy and
[[Page 29773]]
Research Special Emphasis Panel (SEP) meeting.
A Special Emphasis Panel is a group of experts in fields related to
health care research who are invited by the Agency for Healthcare
Research and Quality (AHRQ), and agree to be available, to conduct on
an as needed basis, scientific reviews of applications for AHRQ
support. Individual members of the Panel do not attend regularly-
scheduled meetings and do not serve for fixed terms or a long period of
time. Rather, they are asked to participate in particular review
meetings which require their type of expertise.
Substantial segments of the upcoming SEP meeting listed below will
be closed to the public in accordance with the Federal Advisory
Committee Act, section 10 (d) of 5 U.S.C., Appendix 2 and 5 U.S.C. 552b
(c)(6). Grant applications for the Recovery Act 2009 Limited
Competition: Prospect Studies--Building New Clinical Infrastructure for
CE (R01) applications are to be reviewed and discussed at this meeting.
These discussions are likely to reveal personal information concerning
individuals associated with the applications. This information is
exempt from mandatory disclosure under the above-cited statutes.
SEP Meeting on: Recovery Act 2009 Limited Competition: Prospect
Studies--Building New Clinical Infrastructure for CE (R01).
Dates: June 16, 2010. (Open on June 16 from 8 a.m. to 8:15 a.m.
and closed for the remainder of the meeting.)
Place: Hyatt Regency Hotel, 7400 Wisconsin Avenue, 1 Bethesda
Metro Center, Conference Room TBD, Bethesda, MD 20814.
Contact Person: Anyone wishing to obtain a roster of members,
agenda or minutes of the nonconfidential portions of this meeting
should contact Mrs. Bonnie Campbell, Committee Management Officer,
Office of Extramural Research, Education and Priority Populations,
AHRQ, 540 Gaither Road, Room 2038, Rockville, Maryland 20850,
Telephone (301) 427-1554.
Agenda items for this meeting are subject to change as
priorities dictate.
Dated: May 13, 2010.
Carolyn M. Clancy,
Director.
[FR Doc. 2010-12546 Filed 5-26-10; 8:45 am]
BILLING CODE 4160-90-M
